HDL-Mimetic PLGA Nanoparticle To Target Atherosclerosis Plaque Macrophages
Name
HDL-Mimetic PLGA.pdf
Size
629.05 KB
Format
Adobe PDF
Checksum (MD5)
952d774ed03509ae765c9333bfbe4119
Author(s)
Sanchez-Gaytan, Brenda L.
Fay, Francois
Lobatto, Mark E.
Tang, Jun
Ouimet, Mireille
Kim, YongTae
van der Staay, Susanne E. M.
van Rijs, Sarian M.
Priem, Bram
Zhang, Liangfang
Date Issued
February 2015
Journal
Bioconjugate Chemistry
Publisher
American Chemical Society (ACS)
Citation
Sanchez-Gaytan, Brenda L., Francois Fay, Mark E. Lobatto, Jun Tang, Mireille Ouimet, YongTae Kim, Susanne E. M. van der Staay, et al. “HDL-Mimetic PLGA Nanoparticle To Target Atherosclerosis Plaque Macrophages.” Bioconjugate Chemistry 26, no. 3 (March 18, 2015): 443–451.
Version
Author's final manuscript
Abstract
High-density lipoprotein (HDL) is a natural nanoparticle that exhibits an intrinsic affinity for atherosclerotic plaque macrophages. Its natural targeting capability as well as the option to incorporate lipophilic payloads, e.g., imaging or therapeutic components, in both the hydrophobic core and the phospholipid corona make the HDL platform an attractive nanocarrier. To realize controlled release properties, we developed a hybrid polymer/HDL nanoparticle composed of a lipid/apolipoprotein coating that encapsulates a poly(lactic-co-glycolic acid) (PLGA) core. This novel HDL-like nanoparticle (PLGA–HDL) displayed natural HDL characteristics, including preferential uptake by macrophages and a good cholesterol efflux capacity, combined with a typical PLGA nanoparticle slow release profile. In vivo studies carried out with an ApoE knockout mouse model of atherosclerosis showed clear accumulation of PLGA–HDL nanoparticles in atherosclerotic plaques, which colocalized with plaque macrophages. This biomimetic platform integrates the targeting capacity of HDL biomimetic nanoparticles with the characteristic versatility of PLGA-based nanocarriers.
MIT Department
Massachusetts Institute of Technology. Department of Biological Engineering
Massachusetts Institute of Technology. Department of Chemical Engineering
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1021/bc500517k
